NHS Trusts Fail Cancer Treatment Targets
Analysis based on 11 articles · First reported Feb 24, 2026 · Last updated Feb 25, 2026
The widespread failure of United Kingdom===National Health Service trusts to meet cancer treatment targets in the United Kingdom indicates significant operational challenges and underinvestment in healthcare infrastructure. This could lead to increased public pressure on the government for greater funding and reforms, potentially impacting fiscal policy and the performance of healthcare-related companies.
New data reveals that almost all United Kingdom===National Health Service trusts in England are failing to meet key cancer treatment targets, with some of the worst performers treating only about half of patients within the stipulated 62-day timeframe. The long-standing target of 85% of patients starting treatment within 62 days has not been met nationally since 2014, and only three out of 119 acute trusts achieved this in 2025. An interim target of 75% by March 2026 is also largely missed. Organizations like Cancer Research UK and the Nuffield Trust highlight the need for increased investment in workforce and equipment. Several poorly performing trusts, including National Health Service===Mid and South Essex NHS Foundation Trust and National Health Service===Sheffield Teaching Hospitals NHS Foundation Trust, have acknowledged the issues and are implementing improvement plans. This situation underscores systemic challenges within the United Kingdom's healthcare system, including gaps in investment and staff compared to other European countries.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard